Dr Mark Larkin, CEO of Vitaccess speaks to Robert Pinheiro at Royds Withy King about being an entrepreneur for good in the tech sector.
The Vitaccess team is excited to share new findings of its digital studies in Melanoma and rare diseases Charcot-Marie-Tooth and Beta-Thalassemia.
Here at Vitaccess, the Melanoma UK Digital Registry, run on a mobile application, is our first born.
We have great reason to celebrate this Friday, as we welcome the phenomenal Dr Casey Quinn to our team as Director of Real World Evidence and Analytics.
For those who don’t work in localization of life science materials or clinical research, the answer is yes!
Award-winning digital health company Vitaccess is delighted to announce that, as part of their syndicated project with patient support charity Melanoma UK, they are donating £10,000 towards an Adamo Horus HS800 mole mapper for the Royal Liverpool and Broadgreen University Hospitals NHS Trust.
Co-creating digital apps for observational studies with patients and patient advocacy groups (PAGs) ensures that the apps are tailored to meet the needs of study participants, increasing the likelihood that they are useful in helping to manage their conditions.
On March 27, the German Ministry of Health published a draft revision to the Act for Greater Safety in the Pharmaceutical Supply System.
The Vitaccess team is proud to have been named one of the top 10 rising stars of UK tech in the Tech Nation 2019 competition.
Read the latest blog from our HEOR team on the role of real-world-evidence in health technology assessments for rare diseases.
Vitaccess is upscaling at a thrilling pace! This year marks the rollout of multiple indication RWE apps across Europe, Canada and the USA. The localisation team at Vitaccess is excited to welcome two new members…
To keep up with all our news, please follow us on social media
Oxford Centre for Innovation
New Road
Oxford OX1 1BY
United Kingdom
Tel: +44 1865 818983
This month, the Vitaccess blog looks at the use of online meetings and polling platforms to test product value messages.